pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
rezpegaldesleukin
Alopecia Areata
$NKTRNEKTAR THERAPEUTICS
0 catalysts
Phase 2
rhenium (186Re) obisbemeda
Reyobiq (rhenium (186Re) obisbemeda)
Malignant Glioma
$PSTVPLUS THERAPEUTICS, INC.
0 catalysts
Phase 2
ribaxamase
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
$TOVXTheriva Biologics, Inc.
0 catalysts
← prev
page 45 of 50
next →
131
Pain89
Neurology1
Phase 2
rifamycin
Proctitis
DNA-directed RNA polymerase
Cosmo Pharmaceuticals NV
0 catalysts
Phase 2
rifaquizinone
rifaquizinone [INN]
Prosthetic Joint infections
Tennor Therapeutics (Suzhou) Co., Ltd.
0 catalysts
Phase 2
rigosertib sodium
Non-Small Cell Lung Cancer
$TRAWTraws Pharma, Inc.
0 catalysts
Phase 2
rintatolimod
Ampligen (rintatolimod)
Epithelial Ovarian Cancer
Toll-like receptor 3
$AIMAIM ImmunoTech Inc.
0 catalysts
Phase 2
ristoglogene autogetemcel
ristoglogene autogetemcel [INN]
Beta Thalassaemia
$BEAMBeam Therapeutics Inc.
0 catalysts
Phase 2
risuteganib
Luminate (risuteganib)
Dry (Atrophic) Macular Degeneration
Allegro Ophthalmics LLC
0 catalysts
Phase 2
risvodetinib succinate
Parkinson's Disease
Abli Therapeutics Inc
0 catalysts
Phase 2
rivasterat
rivasterat [INN]
Diabetic Macular Edema
Thea Open Innovation SASU
0 catalysts
Phase 2
rocavorexant
Opium (Opioid) Addiction
$INDVIndivior Pharmaceuticals, Inc.
0 catalysts
Phase 2
roginolisib
roginolisib [INN]
Metastatic Uveal Melanoma
iOnctura SA
0 catalysts
Phase 2
rogocekib
rogocekib [INN]
Chronic Myelomonocytic Leukemia (CMML)
Chordia Therapeutics Inc
0 catalysts
Phase 2
rondaptivon pegol
Hemophilia A (Factor VIII Deficiency)
Band Therapeutics LLC
0 catalysts
Phase 2
rondecabtagene autoleucel
rondecabtagene autoleucel [INN]
Diffuse Large B-Cell Lymphoma
$LYELLyell Immunopharma, Inc.
0 catalysts
Phase 2
ropanicant
ropanicant [INN]
Major Depressive Disorder
Suven Life Sciences Ltd
0 catalysts
Phase 2
rose bengal sodium
rose bengal sodium [INN]
Metastatic Melanoma
$PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
0 catalysts
Phase 2
rosolutamide
rosolutamide [INN]
Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)
Annji Pharmaceutical Co Ltd
0 catalysts
Phase 2
rosopatamab tetraxetan
rosopatamab tetraxetan [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Convergent Therapeutics Inc
0 catalysts
Phase 2
roxadustat
Myelodysplastic Syndrome (Preleukemia)
Hypoxia-inducible factor prolyl hydroxylase
$KYNBKYNTRA BIO, INC.
0 catalysts
Phase 2
ruxoprubart
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
0 catalysts
Phase 2
ruxotemitide
Oncopore (ruxotemitide [INN])
Metastatic Melanoma
Lytix Biopharma ASA
0 catalysts
Phase 2
sabirnetug
Alzheimer's Disease
$ABOSAcumen Pharmaceuticals, Inc.
0 catalysts
Phase 2
sacituzumab drozuntecan
sacituzumab drozuntecan [INN]
Epithelial Ovarian Cancer
$BNTXBioNTech SE
0 catalysts
Phase 2
samelisant
samelisant [INN]
Narcolepsy
Suven Life Sciences Ltd
0 catalysts
Phase 2
sapablursen sodium
Polycythemia Vera
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 2
saracatinib difumarate
Idiopathic Pulmonary Fibrosis
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
sarilumab
Kevzara (sarilumab)
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Interleukin-6 receptor subunit alpha
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 2
satricabtagene autoleucel
Adenocarcinoma Of The Gastroesophageal Junction
CARsgen Therapeutics Holdings Ltd
0 catalysts